- Home
- ROIV vs AAL Comparison
ROIV vs AAL Comparison
Compare ROIV & AAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | AAL |
|---|---|---|
| Founded | 2014 | 1930 |
| Country | United Kingdom | United States |
| Employees | N/A | 133700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1B | 9.6B |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ROIV | AAL |
|---|---|---|
| Price | $39.84 | $13.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 18 |
| Target Price | ★ $28.94 | $15.59 |
| AVG Volume (30 Days) | 7.9M | ★ 61.1M |
| Earning Date | 05-28-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $8,260,000.00 | ★ $54,633,000,000.00 |
| Revenue This Year | N/A | $12.17 |
| Revenue Next Year | $744.61 | $4.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.78 |
| 52 Week Low | $13.94 | $10.09 |
| 52 Week High | $42.50 | $18.79 |
Technical Indicators
Market Signals| Indicator | ROIV | AAL |
|---|---|---|
| Relative Strength Index (RSI) | 63.95 | 35.94 |
| Support Level | $33.15 | $11.97 |
| Resistance Level | $42.50 | $13.37 |
| Average True Range (ATR) | 1.50 | 0.34 |
| MACD | 0.28 | 0.03 |
| Stochastic Oscillator | 78.45 | 18.15 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Dallas/Fort Worth, Charlotte, Chicago, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest average fleet of US legacy carriers.